Skip to content

Welcome to Discover Pharma! Today is : October 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Advanced Therapies
  • Biotech & Pharma Business
  • Central Nervous System
  • Clinical & Regulatory
  • Digital & Data
  • Drug Delivery & Formulation
  • Drug Discovery & Development
  • Genomics and sequencing
  • Manufacturing & Supply Chain
  • Medical devices
  • Opinion & Events
  • Pharmaceuticals and therapeutics
  • Research & Development
  • Therapeutic Areas
  • Uncategorised
  • Digital & Data,Drug Discovery & Development,Research & Development

    Wiley launches spectral analysis APIs for faster compound identification

    read more
  • Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Pusan National University study links stress signalling to immune escape in cold tumours

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Hansa Biopharma treats first commercial kidney transplant patient with Idefirix in Australia

    read more
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    PhaseV survey finds 88% of sponsors face five-week delays in clinical trial reporting

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    NICE recommends glycopyrronium cream for severe underarm sweating

    read more
  • Advanced Therapies,Central Nervous System,Genomics and sequencing,Research & Development

    Researchers develop electromagnetic gene switch for remote control of gene expression

    read more
  • Drug Discovery & Development,Genomics and sequencing,Research & Development

    Tagomics launches cfDNA platform for multi-organ drug safety monitoring

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    NICE recommends allergy immunotherapy tablets for children with hay fever and house dust mite allergy

    read more
  • Biotech & Pharma Business

    Prescient integrates Uptake and Dolon to create 550-strong pharma consultancy

    read more
  • Digital & Data,Pharmaceuticals and therapeutics,Therapeutic Areas

    Tris Pharma partners with Calm Health and ADHD Central to support patients

    read more
  • Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development

    US FDA inspects Aurisco site for generic oligonucleotide manufacturing

    read more
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Remepy raises $36M to advance Parkinson’s drug into Phase 3

    read more
  • Manufacturing & Supply Chain

    University Hospital Cologne selects Celonic for anti-Pseudomonas antibody manufacturing

    read more
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Research & Development

    Tufts analysis finds AI clinical monitoring could cut trial costs and development time

    read more
  • Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Research & Development

    CN Bio wins Innovate UK grant to develop human-relevant drug testing workflow

    read more
  • Clinical & Regulatory,Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease

    read more
Previous678Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Passive cough monitoring linked to worsening asthma symptoms
    Categories: Digital & Data, Drug Discovery & Development, Research & Development, Therapeutic Areas
  • NIH funds expanded access programme for Neurizon’s ALS therapy
    Categories: Advanced Therapies, Biotech & Pharma Business, Central Nervous System, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Sapience Therapeutics gets FDA clearance for ST316 FAP study
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top